Wednesday, July 27, 2022 8:58:10 PM
We all bet here in the past. It is still up to continued efforts by the Company towards a strong future and personal decisions of current and new/prospective shareholders.
One developing drug, Ifenprodil for IPF/CC and cancer tumors. Licensed IP and phase 1+ for new paths with microdosed DMT for stroke treatment. . .
COVID authorities in Australia may be open to long term lung care medications for IPF/CC. There are many with long COVID lung symptoms and a supportive Ausie Clinical Trial system.
...GLTA...
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM